| ²é¿´: 860 | »Ø¸´: 2 | |||
»úÒ©ÈËÔ±Òø³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
¿¨Î¬µØÂåµÄÎïÀíÐÔÖÊ
|
| ÇóÖú¸÷λ´óÏÀ¿¨Î¬µØÂåµÄÎﻯÐÔÖÊ pka Èܽâ¶È µÈµÈ ¶¡Ð· |
» ²ÂÄãϲ»¶
²ÄÁÏ¿¼Ñе÷¼Á
ÒѾÓÐ3È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ12È˻ظ´
Ó¢Ò»ÊýÒ»408£¬×Ü·Ö284£¬¶þÕ½Õæ³ÏÇóµ÷¼Á
ÒѾÓÐ14È˻ظ´
085410 Ò»Ö¾Ô¸211 22408·ÖÊý359Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
271Çóµ÷¼Á
ÒѾÓÐ19È˻ظ´
385·Ö ÉúÎïѧ£¨071000£©Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸°²»Õ´óѧ¼ÆËã»ú¿ÆÑ§Óë¼¼Êõѧ˶£¬331·ÖÇóµ÷¼Á
ÒѾÓÐ3È˻ظ´
318Çóµ÷¼Á£¬¼ÆËã²ÄÁÏ·½Ïò
ÒѾÓÐ8È˻ظ´
291Çóµ÷¼Á
ÒѾÓÐ25È˻ظ´
Ò»Ö¾Ô¸±±¾©¿Æ¼¼´óѧ085601²ÄÁϹ¤³ÌÓ¢Ò»Êý¶þ³õÊÔ×Ü·Ö335Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÂÁµÄÎïÀíÐÔÖÊ£¬»¯Ñ§ÐÔÖÊ£¬¼°ÔÚÈÕ³£Éú»îÖеÄÓÃ;£¨2000ÒÔÉÏ£©
ÒѾÓÐ3È˻ظ´
ÇóÖúÒ»ÖÖÎïÖʵÄÎïÀíÐÔÖÊ
ÒѾÓÐ1È˻ظ´
¹ØÓÚîâËá±µµÄÎïÀí»¯Ñ§ÐÔÖÊ
ÒѾÓÐ3È˻ظ´
¡¾ÇóÖú¡¿¹ØÓÚÂÁ¹èÌúÈýÏàºÏ½ðµÄÎïÀíÐÔÖÊÇóÖú£¬20½ð±Ò
ÒѾÓÐ3È˻ظ´
½ô¼±ÇóÖú Ò»¸ö°±»ùËáµÄÎïÀíÐÔÖÊ£¨¼±£©
ÒѾÓÐ4È˻ظ´
¡¾ÇóÖú¡¿ÇóĪÎ÷ɳÐDzàÁ´Èý¸ö»¯ºÏÎïµÄÈ۵㼰ÎïÀíÐÔÖÊ
ÒѾÓÐ7È˻ظ´
¡¾ÇóÖú¡¿ÎïÀíÐÔÖÊ
ÒѾÓÐ6È˻ظ´
¡¾ÇóÖú¡¿±½¼×ËáÄÆµÄÎïÀíÐÔÖÊ
ÒѾÓÐ7È˻ظ´

³ÕÒÄ×ÓÆ¤
°æÖ÷ (ÎÄ̳¾«Ó¢)
ÀÏÆ¦
- PhEPI: 10
- Ó¦Öú: 2016 (½²Ê¦)
- ¹ó±ö: 5.368
- ½ð±Ò: 54487.3
- É¢½ð: 41688
- ºì»¨: 303
- ɳ·¢: 1206
- Ìû×Ó: 32611
- ÔÚÏß: 4303.7Сʱ
- ³æºÅ: 674536
- ×¢²á: 2008-12-14
- ÐÔ±ð: GG
- רҵ: ÎÞÉñÂÛ
- ¹ÜϽ: ÈËÎÄÉç¿Æ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï
jiangchunyong(½ð±Ò+1): лл 2011-11-21 08:36:38
»úÒ©ÈËÔ±(½ð±Ò+2): ¶àлÀ²£¬Å£ÈË 2011-11-22 00:06:29
jiangchunyong(½ð±Ò+1): лл 2011-11-21 08:36:38
»úÒ©ÈËÔ±(½ð±Ò+2): ¶àлÀ²£¬Å£ÈË 2011-11-22 00:06:29
|
Structural Formula Vector Image Title: Carvedilol CAS Registry Number: 72956-09-3 CAS Name: 1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol Manufacturers' Codes: BM-14190; DQ-2466 Trademarks: Coreg (GSK); Dilatrend (Roche); Dimitone (Erco); Eucardic (Roche); Kredex (GSK); Querto (Byk Gulden) Molecular Formula: C24H26N2O4 Molecular Weight: 406.47 Percent Composition: C 70.92%, H 6.45%, N 6.89%, O 15.74% Literature References: Nonselective b-adrenergic blocker with a1-blocking activity. Prepn: F. Wiedemann et al., DE 2815926; eidem, US 4503067 (1979, 1985 both to Boehringer Mannheim). General pharmacological profile: M. Hirohashi et al., Arzneim.-Forsch. 40, 735 (1990). HPLC determn in biological fluids: K. Reiff, J. Chromatogr. 413, 355 (1987). Series of articles on clinical pharmacology and efficacy in hypertension: J. Cardiovasc. Pharmacol. 19, Suppl. 1, S1-S146 (1992). Clinical trial in chronic heart failure: M. Packer et al., N. Engl. J. Med. 334, 1349 (1996). Review: W. H. Frishman, ibid. 339, 1759-1765 (1998). Properties: Colorless crystals from ethyl acetate, mp 114-115¡ã. Freely sol in DMSO; sol in methylene chloride, methanol; sparingly sol in ethanol, isopropanol; slightly sol in ethyl ether. Practically insol in water. Melting point: mp 114-115¡ã Therap-Cat: Antihypertensive; in treatment of congestive heart failure. Keywords: ?Adrenergic Blocker; Antihypertensive; Aryloxypropanolamine Derivatives. |

2Â¥2011-11-21 08:23:27
ĺÓêÏþ¶É
Òø³æ (Ö°Òµ×÷¼Ò)
- Ó¦Öú: 4 (Ó×¶ùÔ°)
- ½ð±Ò: 25033
- ºì»¨: 4
- Ìû×Ó: 3715
- ÔÚÏß: 65.3Сʱ
- ³æºÅ: 1414373
- ×¢²á: 2011-09-23
- ÐÔ±ð: GG
- רҵ: Óлú·Ö×Ó¹¦ÄܲÄÁÏ»¯Ñ§
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï
qinhy(½ð±Ò+1): ¶àл»ØÌû~ 2011-11-21 19:30:57
»úÒ©ÈËÔ±(½ð±Ò+1): лл£¬ 2011-11-22 00:06:46
qinhy(½ð±Ò+1): ¶àл»ØÌû~ 2011-11-21 19:30:57
»úÒ©ÈËÔ±(½ð±Ò+1): лл£¬ 2011-11-22 00:06:46
| ¿¨Î¬µØÂå ¡¡¡¡Kaweidiluo ¡¡¡¡Carvedilol ¡¡¡¡C24H26N2O4 406.48 ¡¡¡¡±¾Æ·Îª(¡À)-1-(±åßò»ù-4-Ñõ»ù)-3-[2-(ÁÚ-¼×Ñõ»ù±½Ñõ»ù)ÒÒ»ù°·]-2-±û´¼¡£°´¸ÉÔïÆ·¼ÆË㣬º¬C24H26N2O4²»µÃÉÙÓÚ98.5%¡£ ¡¡¡¡¡¾ÐÔ×´¡¿ ±¾Æ·Îª°×É«»òÀà°×É«½á¾§ÐÔ·ÛÄ©£¬ÎÞ³ô¡£ ¡¡¡¡±¾Æ·ÔÚ±ù´×ËáÖÐÒ×ÈÜ£¬ÔÚÈýÂȼ×ÍéÖÐÈܽ⣬ÔÚ¼×´¼»ò´×ËáÒÒõ¥ÖÐÂÔÈÜ£¬ÔÚË®Öв»ÈÜ¡£ ¡¡¡¡È۵㠱¾Æ·µÄÈ۵㣨¸½Â¼VI C£©Îª114¡«118¡æ¡£ ¡¡¡¡¡¾¼ø±ð¡¿ £¨1£©È¡±¾Æ·ÊÊÁ¿£¬¼Ó0.06mol/L ´×ËáÈÜÒºÈܽⲢϡÊÍÖÆ³Éÿ1mlÖÐÔ¼º¬20¦ÌgµÄÈÜÒº£¬ÕÕ×ÏÍ⣿ɼû·Ö¹â¹â¶È·¨£¨¸½Â¼IV A£©²â¶¨£¬ÔÚ285nm¡¢319nmÓë331nmµÄ²¨³¤´¦ÓÐ×î´óÎüÊÕ£¬ÔÚ331nmºÍ285 nm µÄÎü¹â¶È±ÈֵӦΪ0.40¡«0.44¡£ ¡¡¡¡£¨2£©±¾Æ·µÄºìÍâ¹âÎüÊÕͼÆ×Ó¦Óë¶ÔÕÕµÄͼÆ×£¨¹âÆ×¼¯714ͼ£©Ò»Ö¡£ ¡¡¡¡¡¾¼ì²é¡¿ ´×ËáÈÜÒºµÄ³ÎÇå¶ÈÓëÑÕÉ« È¡±¾Æ·0.10g£¬¼Ó6mol/L´×ËáÈÜÒº10mlÈܽâºó£¬ÈÜÒºÓ¦³ÎÇåÎÞÉ«£¬ÈçÏÔÉ«£¬Óë»ÆÉ«2ºÅ±ê×¼±ÈɫҺ£¨¸½Â¼IX AµÚÒ»·¨£©±È½Ï£¬²»µÃ¸üÉî¡£ ¡¡¡¡ÓйØÎïÖÊ ²â¶¨·¨ È¡±¾Æ·ÊÊÁ¿£¬¼ÓÁ÷¶¯ÏàÈܽⲢϡÊÍÖÆ³Éÿ1mlÖк¬0.5mgµÄÈÜÒº£¬×÷Ϊ¹©ÊÔÆ·ÈÜÒº£¬¾«ÃÜÁ¿È¡1ml£¬ÖÃ100mlÁ¿Æ¿ÖУ¬¼ÓÁ÷¶¯ÏàÏ¡ÊÍÖÁ¿Ì¶È£¬Ò¡ÔÈ£¬×÷Ϊ¶ÔÕÕÈÜÒº¡£ÕÕ¸ßЧҺÏàÉ«Æ×·¨£¨¸½Â¼V D£©²â¶¨¡£ÓÃÊ®°ËÍé»ù¹èÍé¼üºÏ¹è½ºÎªÌî³ä¼Á£¬ÒÔÒÒëæ-0.02mol/LÁ×Ëá¶þÇâ¼ØÈÜÒº(Á×Ëáµ÷pH3.5)£¨35:65£©ÎªÁ÷¶¯Ï࣬¼ì²â²¨³¤Îª241nm£¬È¡±¾Æ·Ô¼12.5mg£¬ÖÃ×¶ÐÎÆ¿ÖУ¬¼ÓÈë5mol/LÑÎËáÈÜÒº5ml£¬ÓÚ95¡æ¼ÓÈÈ3Сʱ£¬·ÅÀäÖÁÊÒΣ¬¼Ó5moll/LÇâÑõ»¯ÄÆÈÜÒº5ml£¬¼ÓÁ÷¶¯Ïà15ml³¬Éù´¦Àí10·ÖÖÓ£¬Ò¡ÔÈ£¬Â˹ý£¬È¡ÂËÒº10ul×¢ÈëÒºÏàÉ«Æ×ÒÇ£¬ÀíÂÛ°åÊý°´¿¨Î¬µØÂå·å¼ÆËãÓ¦²»µÍÓÚ2000£¬¿¨Î¬µØÂåÖ÷·åÓëÆäºóµÄ×î´ó½µ½â²úÎï·åµÄ·ÖÀë¶ÈÓ¦´óÓÚ6.5¡£È¡¶ÔÕÕÈÜÒº10¦Ìl×¢ÈëÒºÏàÉ«Æ×ÒÇ£¬µ÷½Ú¼ì²âÁéÃô¶È£¬Ê¹Ö÷³É·ÖÉ«Æ×·åµÄ·å¸ßԼΪÂúÁ¿³ÌµÄ10%¡«20%£»ÔÙ¾«ÃÜÁ¿È¡ÉÏÊöÁ½ÖÖÈÜÒº¸÷10¦Ìl£¬·Ö±ð×¢ÈëÒºÏàÉ«Æ×ÒÇ£¬¼Ç¼ɫÆ×ͼÖÁÖ÷·å±£Áôʱ¼äµÄ3.5±¶¡£¹©ÊÔÆ·ÈÜÒºµÄÉ«Æ×ͼÖÐÈçÓÐÔÓÖʷ壬µ¥¸öÔÓÖÊ·åÃæ»ý²»µÃ´óÓÚ¶ÔÕÕÈÜÒºÖ÷·åÃæ»ýµÄ0.2±¶£¨0.2%£©£¬¸÷ÔÓÖÊ·åÃæ»ýµÄºÍ²»µÃ´óÓÚ¶ÔÕÕÈÜÒºÖ÷·åÃæ»ýµÄ0.5±¶£¨0.5%£©¡£ ¡¡¡¡¸ÉÔïÊ§ÖØ È¡±¾Æ·£¬ÒÔÎåÑõ»¯¶þÁ×Ϊ¸ÉÔï¼Á£¬¼õѹ¸ÉÔïÖÁºãÖØ£¬¼õÊ§ÖØÁ¿²»µÃ¹ý0.5%£¨¸½Â¼¢ø L£©¡£ ¡¡¡¡³ãׯ²ÐÔü È¡±¾Æ·1.0g£¬ÒÀ·¨¼ì²é£¨¸½Â¼¢ø N£©£¬ÒÅÁô²ÐÔü²»µÃ¹ý0.1%¡£ ¡¡¡¡ÖؽðÊô È¡³ãׯ²ÐÔüÏîÏÂÒÅÁôµÄ²ÐÔü£¬ÒÀ·¨¼ì²é£¨¸½Â¼¢ø HµÚ¶þ·¨£©£¬º¬ÖؽðÊô²»µÃ¹ý°ÙÍò·Ö֮ʮ¡£¡¡ ¡¡¡¡¡¾º¬Á¿²â¶¨¡¿ È¡±¾Æ·Ô¼0.3g£¬¾«Ãܳƶ¨£¬¼Ó±ù´×Ëá30mlÈܽâºó£¬ÕÕµçλµÎ¶¨·¨£¨¸½Â¼VII A£©£¬ÓøßÂÈËáµÎ¶¨Òº£¨0.1mol/L£©µÎ¶¨£¬²¢½«µÎ¶¨½á¹ûÓÿհ×ÊÔÑéУÕý¡£Ã¿1mlµÄ¸ßÂÈËáµÎ¶¨Òº£¨0.1mol/L£©Ï൱ÓÚ40.65mgµÄC24H26N2O4¡£ |

3Â¥2011-11-21 18:49:13














»Ø¸´´ËÂ¥